As Biotechnology companies, Outlook Therapeutics Inc. (NASDAQ:OTLK) and Global Cord Blood Corporation (NYSE:CO) are our subject to contrast. And more specifically their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation.

Valuation & Earnings

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outlook Therapeutics Inc.	3.38M	10.19	40.18M	-0.90	0.00
Global Cord Blood Corporation	N/A	0.00	N/A	0.28	26.39

Demonstrates Outlook Therapeutics Inc. and Global Cord Blood Corporation earnings per share, top-line revenue and valuation.

Profitability

Table 2 has Outlook Therapeutics Inc. and Global Cord Blood Corporation’s return on equity, return on assets and net margins.

	Net Margins	Return on Equity	Return on Assets
Outlook Therapeutics Inc.	-1,188.76%	158.6%	-156.3%
Global Cord Blood Corporation	0.00%	7.2%	3.8%

Liquidity

The Current Ratio and Quick Ratio of Outlook Therapeutics Inc. are 0.1 and 0.1 respectively. Its competitor Global Cord Blood Corporation’s Current Ratio is 9.7 and its Quick Ratio is 9.6. Global Cord Blood Corporation can pay off short and long-term obligations better than Outlook Therapeutics Inc.

Dividends

On the other side, $0.08 per share with a dividend yield of 1.06% for Global Cord Blood Corporation. Outlook Therapeutics Inc. does not pay a dividend.

Institutional and Insider Ownership

Institutional investors held 4.8% of Outlook Therapeutics Inc. shares and 17.4% of Global Cord Blood Corporation shares. 7.8% are Outlook Therapeutics Inc.’s share held by insiders. Insiders Competitively, held 49.6% of Global Cord Blood Corporation shares.

Performance

Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

	Performance (W)	Performance (M)	Performance (Q)	Performance (HY)	Performance (Y)	Performance (YTD)
Outlook Therapeutics Inc.	3.7%	46.4%	65.44%	25.98%	-1.75%	124%
Global Cord Blood Corporation	3.79%	17.68%	15.29%	6.79%	-29.82%	14.57%

For the past year Outlook Therapeutics Inc. has stronger performance than Global Cord Blood Corporation

Summary

Global Cord Blood Corporation beats on 7 of the 11 factors Outlook Therapeutics Inc.

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).